ChitogenX, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA1699161032
CAD
0.01
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About ChitogenX, Inc. stock-summary
stock-summary
ChitogenX, Inc.
Pharmaceuticals & Biotechnology
Ortho Regenerative Technologies Inc is a Canada-based biotechnology company. The Company is developing a platform for the repair of tears to soft tissues in joints, and for articular cartilage repair, to restore healthy joint motion and prevent or delay osteoarthritis. The Company's initial focus is in creating new treatments for tears to the meniscus in the knee and the shoulder cuff. The Company's biopolymer has been designed for the healing rates of sports related injuries to ligaments, tendons and cartilage. The polymer can be directly placed into the site of injury by a surgeon during a routine operative procedure without significantly extending the time of the surgery and without further intervention.
Company Coordinates stock-summary
Company Details
16667 Hymus Blvd , KIRKLAND QC : H9H 4R9
stock-summary
Tel: 1 514 7828804
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Brent Norton
Executive Co-Chairman of the Board, Acting Chief Executive Officer
Mr. Steven Saviuk
Executive Co-Chairman of the Board
Mr. Michael Buschmann
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Oct 2024)
Net Profit:
-1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 0 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.57

stock-summary
Return on Equity

28.76%

stock-summary
Price to Book

-0.06